PROM1 and neoplasm: 64Cu-ATSM decreases number of CD133+ cells not by specific interactions, but rather by accumulating within regions of tumor with high abundance of CD133+ cells, which results in higher doses of radiation in that areas (Yoshii et al. 2011).